Review Published on 02 Feb 2023 Commercial and business aspects of alpha radioligand therapeutics in Nuclear Medicine Emanuele OstuniMartin R. G. Taylor Frontiers in Medicine doi 10.3389/fmed.2022.1070497 19,916 views 30 citations